ID   SGK1_HUMAN              Reviewed;         431 AA.
AC   O00141; B7UUP7; B7UUP8; B7UUP9; B7Z5B2; Q5TCN2; Q5TCN3; Q5TCN4;
AC   Q5VY65; Q9UN56;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 2.
DT   02-NOV-2010, entry version 110.
DE   RecName: Full=Serine/threonine-protein kinase Sgk1;
DE            EC=2.7.11.1;
DE   AltName: Full=Serum/glucocorticoid-regulated kinase 1;
GN   Name=SGK1; Synonyms=SGK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=97272242; PubMed=9114008; DOI=10.1073/pnas.94.9.4440;
RA   Waldegger S., Barth P., Raber G., Lang F.;
RT   "Cloning and characterization of a putative human serine/threonine
RT   protein kinase transcriptionally modified during anisotonic and
RT   isotonic alterations of cell volume.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:4440-4445(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING (ISOFORM
RP   1).
RX   MEDLINE=98390195; PubMed=9722955; DOI=10.1006/geno.1998.5258;
RA   Waldegger S., Erdel M., Nagl U.O., Barth P., Raber G., Steuer S.,
RA   Utermann G., Paulmichl M., Lang F.;
RT   "Genomic organization and chromosomal localization of the human SGK
RT   protein kinase gene.";
RL   Genomics 51:299-302(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, ALTERNATIVE PROMOTER
RP   USAGE, INDUCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=18753299; DOI=10.1152/ajprenal.90239.2008;
RA   Raikwar N.S., Snyder P.M., Thomas C.P.;
RT   "An evolutionarily conserved N-terminal Sgk1 variant with enhanced
RT   stability and improved function.";
RL   Am. J. Physiol. 295:F1440-F1448(2008).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3; 4 AND 5), AND ALTERNATIVE
RP   PROMOTER USAGE.
RC   TISSUE=Glioblastoma, Hippocampus, and Skin;
RA   Hall B.A., Blakeley S., Daniels N.A., Jamieson D., Brickley D.,
RA   Reynolds N.J., Conzen S.D., Jackson T.R.;
RT   "Transcriptional variants of serum/glucocorticoid regulated kinase 1
RT   show differential localisation and regulation.";
RL   Submitted (AUG-2008) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hair follicle dermal papilla;
RA   Kim M.K., Kim Y.H., Seo J.M., Lee H.M., Chung H.J., Sohn M.Y.,
RA   Hwang S.Y., Im S.U., Jung E.J., Lee J.H., Kim J.C.;
RT   "A catalogue of genes in the human dermal papilla cells as identified
RT   by expressed sequence tags.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   MEDLINE=20018032; PubMed=10548550; DOI=10.1042/0264-6021:3440189;
RA   Kobayashi T., Deak M., Morrice N., Cohen P.;
RT   "Characterization of the structure and regulation of two novel
RT   isoforms of serum- and glucocorticoid-induced protein kinase.";
RL   Biochem. J. 344:189-197(1999).
RN   [11]
RP   PHOSPHORYLATION AT THR-256 AND SER-422, AND MUTAGENESIS OF THR-256 AND
RP   SER-422.
RC   TISSUE=Brain;
RX   MEDLINE=99208518; PubMed=10191262; DOI=10.1042/0264-6021:3390319;
RA   Kobayashi T., Cohen P.;
RT   "Activation of serum- and glucocorticoid-regulated protein kinase by
RT   agonists that activate phosphatidylinositide 3-kinase is mediated by
RT   3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2.";
RL   Biochem. J. 339:319-328(1999).
RN   [12]
RP   CHARACTERIZATION.
RX   MEDLINE=20345128; PubMed=10884438; DOI=10.1073/pnas.97.14.8157;
RA   Lang F., Klingel K., Wagner C.A., Stegen C., Waerntges S.,
RA   Friedrich B., Lanzendoerfer M., Melzig J., Moschen I., Steuer S.,
RA   Waldegger S., Sauter M., Paulmichl M., Gerke V., Risler T., Gamba G.,
RA   Capasso G., Kandolf R., Hebert S.C., Massry S.G., Broer S.;
RT   "Deranged transcriptional regulation of cell-volume-sensitive kinase
RT   hSGK in diabetic nephropathy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:8157-8162(2000).
RN   [13]
RP   FUNCTION.
RX   MEDLINE=20584913; PubMed=11154281; DOI=10.1128/MCB.21.3.952-965.2001;
RA   Brunet A., Park J., Tran H., Hu L.S., Hemmings B.A., Greenberg M.E.;
RT   "Protein kinase SGK mediates survival signals by phosphorylating the
RT   forkhead transcription factor FKHRL1 (FOXO3a).";
RL   Mol. Cell. Biol. 21:952-965(2001).
RN   [14]
RP   INTERACTION WITH NEDD4 AND NEDD4L, MUTAGENESIS OF LYS-127; TYR-298 AND
RP   SER-422, AND FUNCTION.
RX   PubMed=11696533; DOI=10.1074/jbc.C100623200;
RA   Snyder P.M., Olson D.R., Thomas B.C.;
RT   "Serum and glucocorticoid-regulated kinase modulates Nedd4-2-mediated
RT   inhibition of the epithelial Na+ channel.";
RL   J. Biol. Chem. 277:5-8(2002).
RN   [15]
RP   FUNCTION.
RX   MEDLINE=22284526; PubMed=12397388; DOI=10.1007/s00424-002-0873-2;
RA   Gamper N., Fillon S., Feng Y., Friedrich B., Lang P.A., Henke G.,
RA   Huber S.M., Kobayashi T., Cohen P., Lang F.;
RT   "K(+) channel activation by all three isoforms of serum- and
RT   glucocorticoid-dependent protein kinase SGK.";
RL   Pflugers Arch. 445:60-66(2002).
RN   [16]
RP   FUNCTION, AND MUTAGENESIS OF LYS-127 AND SER-422.
RX   PubMed=12911626;
RA   Boehmer C., Henke G., Schniepp R., Palmada M., Rothstein J.D.,
RA   Broeer S., Lang F.;
RT   "Regulation of the glutamate transporter EAAT1 by the ubiquitin ligase
RT   Nedd4-2 and the serum and glucocorticoid-inducible kinase isoforms
RT   SGK1/3 and protein kinase B.";
RL   J. Neurochem. 86:1181-1188(2003).
RN   [17]
RP   NUCLEAR LOCALIZATION SIGNAL.
RX   MEDLINE=22519459; PubMed=12631736; DOI=10.1091/mbc.E02-03-0170;
RA   Maiyar A.C., Leong M.L., Firestone G.L.;
RT   "Importin-alpha mediates the regulated nuclear targeting of serum- and
RT   glucocorticoid-inducible protein kinase (Sgk) by recognition of a
RT   nuclear localization signal in the kinase central domain.";
RL   Mol. Biol. Cell 14:1221-1239(2003).
RN   [18]
RP   FUNCTION, AND MUTAGENESIS OF LYS-127 AND SER-422.
RX   PubMed=15040001; DOI=10.1002/jcp.10430;
RA   Henke G., Maier G., Wallisch S., Boehmer C., Lang F.;
RT   "Regulation of the voltage gated K+ channel Kv1.3 by the ubiquitin
RT   ligase Nedd4-2 and the serum and glucocorticoid inducible kinase
RT   SGK1.";
RL   J. Cell. Physiol. 199:194-199(2004).
RN   [19]
RP   UBIQUITINATION.
RX   PubMed=15576372; DOI=10.1074/jbc.M411053200;
RA   Zhou R., Snyder P.M.;
RT   "Nedd4-2 phosphorylation induces serum and glucocorticoid-regulated
RT   kinase (SGK) ubiquitination and degradation.";
RL   J. Biol. Chem. 280:4518-4523(2005).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74; SER-78; SER-397 AND
RP   SER-401, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [21]
RP   ALTERNATIVE PROMOTER USAGE (ISOFORMS 2 AND 3).
RX   PubMed=18334630; DOI=10.1073/pnas.0800958105;
RA   Arteaga M.F., Coric T., Straub C., Canessa C.M.;
RT   "A brain-specific SGK1 splice isoform regulates expression of ASIC1 in
RT   neurons.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:4459-4464(2008).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74; SER-78; SER-397 AND
RP   SER-401, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [23]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-219 AND VAL-342.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Protein kinase that plays an important role in cellular
CC       stress response. Activates certain potassium, sodium, and chloride
CC       channels, suggesting an involvement in the regulation of processes
CC       such as cell survival, neuronal excitability and renal sodium
CC       excretion. Sustained high levels and activity may contribute to
CC       conditions such as hypertension and diabetic nephropathy. Mediates
CC       cell survival signals, phosphorylates and negatively regulates
CC       pro-apoptotic FOXO3A. Phosphorylates NEDD4L, which leads to its
CC       inactivation and to the subsequent activation of various channels
CC       and transporters such as ENaC, KCNA3/Kv1.3 or EAAT1. Isoform 2
CC       exhibited a greater effect on cell plasma membrane expression of
CC       ENaC and Na(+) transport than isoform 1.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Two specific sites, one in the kinase domain
CC       (Thr-256) and the other in the C-terminal regulatory region (Ser-
CC       422), need to be phosphorylated for its full activation.
CC   -!- SUBUNIT: Interacts with NEDD4 and NEDD4L.
CC   -!- INTERACTION:
CC       P25942:CD40; NbExp=1; IntAct=EBI-1042854, EBI-525714;
CC       Q16543:CDC37; NbExp=1; IntAct=EBI-1042854, EBI-295634;
CC       P02788:LTF; NbExp=1; IntAct=EBI-1042854, EBI-1058602;
CC       Q9UQ80:PA2G4; NbExp=1; IntAct=EBI-1042854, EBI-924893;
CC       O15530:PDPK1; NbExp=1; IntAct=EBI-1042854, EBI-717097;
CC       P01833:PIGR; NbExp=1; IntAct=EBI-1042854, EBI-1052371;
CC       P49411:TUFM; NbExp=1; IntAct=EBI-1042854, EBI-359097;
CC       Q5VYM0:VCP; NbExp=1; IntAct=EBI-1042854, EBI-1046421;
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cell membrane.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Endoplasmic reticulum.
CC       Note=Nuclear, upon phosphorylation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O00141-1; Sequence=Displayed;
CC       Name=2; Synonyms=Sgk1.1, Sgk1_v2;
CC         IsoId=O00141-2; Sequence=VSP_037784;
CC         Note=Produced by alternative promoter usage;
CC       Name=3; Synonyms=Sgk1.2;
CC         IsoId=O00141-3; Sequence=VSP_037785;
CC         Note=Produced by alternative promoter usage;
CC       Name=4;
CC         IsoId=O00141-4; Sequence=VSP_037786;
CC         Note=Produced by alternative splicing of isoform 1;
CC       Name=5;
CC         IsoId=O00141-5; Sequence=VSP_037787;
CC         Note=Produced by alternative promoter usage;
CC   -!- TISSUE SPECIFICITY: Expressed in most tissues with highest levels
CC       in the pancreas, followed by placenta, kidney and lung. Isoform 2
CC       is strongly expressed in brain and pancreas, weaker in heart,
CC       placenta, lung, liver and skeletal muscle.
CC   -!- INDUCTION: Isoform 1 is induced by serum and/or glucocorticoids.
CC       Isoform 2 is not induced by glucocorticoids. By excessive
CC       extracellular glucose and by TGFB1, in cultured cells.
CC   -!- DOMAIN: Isoform 2 subcellular localization at the plasma membrane
CC       is mediated by the sequences within the first 120 amino acids.
CC   -!- PTM: Regulated by phosphorylation. Phosphoinositide 3-kinase (PI3-
CC       kinase) pathway promotes phosphorylation at Ser-422 which in turn
CC       increases the phosphorylation of Thr-256 by PDPK1.
CC   -!- PTM: Ubiquitinated by NEDD4L; which promotes proteasomal
CC       degradation. Ubiquitinated by SYVN1 at the endoplasmic reticulum;
CC       which promotes rapid proteasomal degradation and maintains a high
CC       turnover rate in resting cells. Isoform 2 shows enhanced
CC       stability. Isoform 2 resistance to proteasomal degradation is
CC       mediated by the sequences within the first 120-amino acid.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y10032; CAA71138.1; -; mRNA.
DR   EMBL; AJ000512; CAA04146.1; -; Genomic_DNA.
DR   EMBL; EU518415; ACD35864.1; -; mRNA.
DR   EMBL; FM205707; CAR58095.1; -; mRNA.
DR   EMBL; FM205708; CAR58096.1; -; mRNA.
DR   EMBL; FM205709; CAR58097.1; -; mRNA.
DR   EMBL; FM205710; CAR58098.1; -; mRNA.
DR   EMBL; AF153609; AAD41091.1; -; mRNA.
DR   EMBL; AK055077; BAG51463.1; -; mRNA.
DR   EMBL; AK298688; BAH12848.1; -; mRNA.
DR   EMBL; AL355881; CAH72579.1; -; Genomic_DNA.
DR   EMBL; AL135839; CAH72579.1; JOINED; Genomic_DNA.
DR   EMBL; Z84486; CAH72579.1; JOINED; Genomic_DNA.
DR   EMBL; AL135839; CAI19718.1; -; Genomic_DNA.
DR   EMBL; AL135839; CAI19719.1; -; Genomic_DNA.
DR   EMBL; AL135839; CAI19720.1; -; Genomic_DNA.
DR   EMBL; AL135839; CAI19721.1; -; Genomic_DNA.
DR   EMBL; AL355881; CAI19721.1; JOINED; Genomic_DNA.
DR   EMBL; Z84486; CAI19721.1; JOINED; Genomic_DNA.
DR   EMBL; Z84486; CAI21678.1; -; Genomic_DNA.
DR   EMBL; AL135839; CAI21678.1; JOINED; Genomic_DNA.
DR   EMBL; AL355881; CAI21678.1; JOINED; Genomic_DNA.
DR   EMBL; CH471051; EAW47991.1; -; Genomic_DNA.
DR   EMBL; BC001263; AAH01263.1; -; mRNA.
DR   IPI; IPI00297590; -.
DR   IPI; IPI00479349; -.
DR   IPI; IPI00514242; -.
DR   IPI; IPI00645903; -.
DR   IPI; IPI00917765; -.
DR   RefSeq; NP_001137148.1; -.
DR   RefSeq; NP_001137149.1; -.
DR   RefSeq; NP_001137150.1; -.
DR   RefSeq; NP_005618.2; -.
DR   UniGene; Hs.510078; -.
DR   PDB; 2R5T; X-ray; 1.90 A; A=60-431.
DR   PDB; 3HDM; X-ray; 2.60 A; A=60-431.
DR   PDB; 3HDN; X-ray; 3.10 A; A=60-431.
DR   PDBsum; 2R5T; -.
DR   PDBsum; 3HDM; -.
DR   PDBsum; 3HDN; -.
DR   ProteinModelPortal; O00141; -.
DR   IntAct; O00141; 50.
DR   MINT; MINT-1338693; -.
DR   STRING; O00141; -.
DR   PhosphoSite; O00141; -.
DR   PRIDE; O00141; -.
DR   Ensembl; ENST00000237305; ENSP00000237305; ENSG00000118515.
DR   GeneID; 6446; -.
DR   KEGG; hsa:6446; -.
DR   UCSC; uc003qen.2; human.
DR   CTD; 6446; -.
DR   GeneCards; GC06M134490; -.
DR   H-InvDB; HIX0006234; -.
DR   HGNC; HGNC:10810; SGK1.
DR   HPA; CAB022085; -.
DR   HPA; CAB025148; -.
DR   MIM; 602958; gene.
DR   PharmGKB; PA35721; -.
DR   eggNOG; prNOG07870; -.
DR   HOVERGEN; HBG108317; -.
DR   OMA; DFMEIKN; -.
DR   PhylomeDB; O00141; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; pi3kcipathway; Class I PI3K signaling events.
DR   Pathway_Interaction_DB; foxopathway; FoxO family signaling.
DR   Pathway_Interaction_DB; insulin_pathway; Insulin Pathway.
DR   NextBio; 25053; -.
DR   ArrayExpress; O00141; -.
DR   Bgee; O00141; -.
DR   CleanEx; HS_SGK1; -.
DR   Genevestigator; O00141; -.
DR   GermOnline; ENSG00000118515; Homo sapiens.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0006915; P:apoptosis; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; TAS:ProtInc.
DR   GO; GO:0006950; P:response to stress; TAS:ProtInc.
DR   GO; GO:0006814; P:sodium ion transport; TAS:ProtInc.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative promoter usage; Alternative splicing;
KW   Apoptosis; ATP-binding; Cell membrane; Complete proteome; Cytoplasm;
KW   Endoplasmic reticulum; Kinase; Membrane; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Stress response; Transferase; Ubl conjugation.
FT   CHAIN         1    431       Serine/threonine-protein kinase Sgk1.
FT                                /FTId=PRO_0000086642.
FT   DOMAIN       98    355       Protein kinase.
FT   DOMAIN      356    431       AGC-kinase C-terminal.
FT   NP_BIND     104    112       ATP (By similarity).
FT   REGION        1     60       Necessary for localization to the
FT                                cytoplasm.
FT   MOTIF       131    141       Nuclear localization signal.
FT   COMPBIAS    131    141       Glu/Lys-rich.
FT   ACT_SITE    222    222       Proton acceptor (By similarity).
FT   BINDING     127    127       ATP (By similarity).
FT   MOD_RES      74     74       Phosphoserine.
FT   MOD_RES      78     78       Phosphoserine.
FT   MOD_RES     256    256       Phosphothreonine; by PDPK1.
FT   MOD_RES     397    397       Phosphoserine.
FT   MOD_RES     401    401       Phosphoserine.
FT   MOD_RES     422    422       Phosphoserine.
FT   VAR_SEQ       1     25       MTVKTEAAKGTLTYSRMRGMVAILI -> MVNKDMNGFPVK
FT                                KCSAFQFFKKRVRRWIKSPMVSVDKHQSPSLKYTGSSMVHI
FT                                PPGEPDFESSLCQTCLGEHAFQRGVLPQENESCSWETQSGC
FT                                EVREPCNHANILTKPDPRTFWTNDDP (in isoform
FT                                2).
FT                                /FTId=VSP_037784.
FT   VAR_SEQ       1     25       MTVKTEAAKGTLTYSRMRGMVAILI -> MGEMQGALARAR
FT                                LESLLRPRHKKRAEAQKRSESFLLSGL (in isoform
FT                                3).
FT                                /FTId=VSP_037785.
FT   VAR_SEQ       1     25       MTVKTEAAKGTLTYSRMRGMVAILI -> MKPSKRFFISPP
FT                                SST (in isoform 4).
FT                                /FTId=VSP_037786.
FT   VAR_SEQ       1     25       MTVKTEAAKGTLTYSRMRGMVAILI -> MSSQSSSLSEAC
FT                                SREAYSSHNWALPPASRSNPQPAYPWATRRMKEEAIKPPLK
FT                                (in isoform 5).
FT                                /FTId=VSP_037787.
FT   VARIANT     219    219       V -> I (in dbSNP:rs34133418).
FT                                /FTId=VAR_041071.
FT   VARIANT     342    342       A -> V (in dbSNP:rs55932330).
FT                                /FTId=VAR_041072.
FT   MUTAGEN     127    127       K->M: Abolishes enzymatic activity.
FT   MUTAGEN     256    256       T->A: Low activity.
FT   MUTAGEN     256    256       T->D: Low activity.
FT   MUTAGEN     256    256       T->E: Low activity.
FT   MUTAGEN     298    298       Y->A: Abolishes interaction with NEDD4
FT                                and NEDD4L.
FT   MUTAGEN     422    422       S->A: Low activity.
FT   MUTAGEN     422    422       S->D: 10-fold activation.
FT   CONFLICT     62     62       Q -> E (in Ref. 4; CAR58097).
FT   CONFLICT    152    152       K -> R (in Ref. 4; CAR58096).
FT   CONFLICT    196    196       E -> G (in Ref. 4; CAR58095).
FT   CONFLICT    228    228       I -> V (in Ref. 6; BAH12848).
FT   CONFLICT    371    371       P -> R (in Ref. 4; CAR58097).
FT   CONFLICT    381    381       D -> E (in Ref. 1; CAA71138 and 2;
FT                                CAA04146).
FT   HELIX        95     97
FT   STRAND       98    103
FT   STRAND      112    117
FT   TURN        118    120
FT   STRAND      123    130
FT   HELIX       131    133
FT   STRAND      164    167
FT   STRAND      169    177
FT   HELIX       184    191
FT   HELIX       196    209
FT   HELIX       214    216
FT   HELIX       225    227
FT   STRAND      228    230
FT   STRAND      236    238
FT   HELIX       245    247
FT   HELIX       266    269
FT   HELIX       277    282
FT   HELIX       286    291
FT   HELIX       302    311
FT   STRAND      318    320
FT   HELIX       322    328
FT   HELIX       336    338
FT   HELIX       346    350
FT   HELIX       353    355
FT   HELIX       360    364
SQ   SEQUENCE   431 AA;  48942 MW;  F3697C63AB1F499D CRC64;
     MTVKTEAAKG TLTYSRMRGM VAILIAFMKQ RRMGLNDFIQ KIANNSYACK HPEVQSILKI
     SQPQEPELMN ANPSPPPSPS QQINLGPSSN PHAKPSDFHF LKVIGKGSFG KVLLARHKAE
     EVFYAVKVLQ KKAILKKKEE KHIMSERNVL LKNVKHPFLV GLHFSFQTAD KLYFVLDYIN
     GGELFYHLQR ERCFLEPRAR FYAAEIASAL GYLHSLNIVY RDLKPENILL DSQGHIVLTD
     FGLCKENIEH NSTTSTFCGT PEYLAPEVLH KQPYDRTVDW WCLGAVLYEM LYGLPPFYSR
     NTAEMYDNIL NKPLQLKPNI TNSARHLLEG LLQKDRTKRL GAKDDFMEIK SHVFFSLINW
     DDLINKKITP PFNPNVSGPN DLRHFDPEFT EEPVPNSIGK SPDSVLVTAS VKEAAEAFLG
     FSYAPPTDSF L
//
